BioSpace News Archive

All Criteria for the Response-Based Endpoint Now Finalized

Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis

WellCare Health Plans, Inc. and AbleTo, a leading provider of virtual behavioral healthcare, announced the launch of a new program to serve WellCare’s Medicare Advantage members in New York.

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics (Nasdaq: CARA) on the successful initiation of its Phase 2 clinical trial of Oral KORSUVA™ (CR845/difelikefalin) for the treatment of pruritus in patients with atopic dermatitis (AD).

− Announces Planned Appointment of Jeff Poulton − Manmeet S. Soni to Resign After a Transition Period

Juvenescence, a life sciences company targeting the intrinsic mechanisms of aging, announces that Colin Watts has joined its Management Team as CEO of Juvenescence Life.

On July 10th, Chengdu Hi-tech Zone and Gilead Sciences inked a strategic cooperation agreement on the Gilead Sciences Western China Operation Center project, which marked the official registration of its western China operation center in Chengdu Hi-tech Zone.

ObjectiveGI is delivering provider partners and their patients participating in research a new, all-inclusive platform of clinical research data management.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today reports the publication of a new, independent study using NervGen’s core Intracellular Sigma Peptide (“ISP”) technology in a mouse model representative of demyelination in multiple sclerosis.

RaySearch has received 510 clearance from the FDA in the USA for version 8B of the treatment planning system RayStation®.